Home / Applications / Cosmetics / Lutein Dimer Bioproduction Engineering Service

Lutein Dimer Bioproduction Engineering Service

Lutein Dimer ( Lutein Epoxide Dimer or other functionalized Lutein dimers ) is a promising carotenoid derivative with potentially enhanced antioxidant properties for the pharmaceutical and cosmetic industries. Current production methods, often relying on semi-synthesis from naturally sourced Lutein , involve multiple steps in chemical synthesis . These steps are inefficient, generate toxic waste, and lack stereoselectivity. The resulting product often exhibits low activity due to contamination with inactive isomers and impurities generated during the harsh chemical process. Biosynthesis offers a superior, greener, and more stereoselective alternative.

CD Biosynsis offers a synthetic biology service focused on the clean and efficient production of specific Lutein Dimers using Escherichia coli ( E. coli ). Our core strategy begins with modification of lutein synthesis pathway in Escherichia coli . This involves engineering E. coli 's native central metabolism ( Glycolysis and MEP Pathway ) to boost the supply of the Isoprenoid precursor ( IPP ), followed by the heterologous expression and optimization of the complete Lutein pathway ( CrtE , B , I , Y , Z , E etc.) to maximize the concentration of the Lutein intermediate. The key innovation is the directed evolution of dimerization enzyme . We introduce a specific enzyme ( e.g. , a novel oxidase or coupling synthase ) that catalyzes the selective dimerization of Lutein or its functionalized derivatives. We then apply directed evolution techniques ( error - prone PCR , DNA shuffling ) to this enzyme to dramatically enhance its catalytic efficiency and stereoselectivity for the desired Dimer isomer . This integrated approach solves the multiple steps in chemical synthesis challenge by replacing it with a single, highly selective enzymatic step, ensuring the production of the isomer with the highest activity and purity.

Get a Quote
Pain Points Solutions Advantages Process FAQ

Pain Points

Developing a high-quality Lutein Dimer product faces these key challenges:

  • Multiple Steps in Chemical Synthesis: Chemical modification and dimerization of Lutein requires many protection and deprotection steps , harsh reaction conditions, and difficult purification , leading to high cost and poor yield.
  • Low Activity: Chemical methods lack the required stereoselectivity, producing a mixture of inactive or less-active isomers , which reduces the overall commercial bioactivity of the final product.
  • Lutein Pathway Complexity: Reconstituting the Lutein pathway ( CrtY , Z , E etc.) in E. coli requires the coordination of multiple heterologous genes and optimizing the flux of the MEP precursor pathway.
  • Dimerization Selectivity: The newly introduced Dimerization Enzyme must be highly selective to create the desired dimer structure without forming side products or non-specific couplings.

A successful solution must ensure robust Lutein production and introduce a highly selective, optimized dimerization biocatalyst.

Solutions

CD Biosynsis utilizes advanced metabolic and enzyme engineering to optimize Lutein Dimer production in E. coli :

Modification of Lutein Synthesis Pathway in E. coli

           

We upregulate the native MEP pathway and co-express the complete heterologous Lutein gene cluster ( CrtE , B , I , Y , Z , E ) for maximal Lutein precursor supply.

Directed Evolution of Dimerization Enzyme

We apply high - throughput screening and mutagenesis to a promising Dimerization Enzyme to enhance its catalytic activity and regioselectivity for the Lutein Dimer .

Metabolic Precursor Optimization

We delete competing central metabolism pathways ( e.g. , acetate production pathway ) to ensure maximum carbon flux is directed into the MEP pathway.

Enzyme Compartmentalization

We use protein scaffolds or microcompartments to co-localize Lutein pathway enzymes and the Dimerization Enzyme , enhancing metabolic efficiency.

This systematic approach ensures high Lutein supply and a highly specific enzymatic conversion to the Dimer .

Advantages

Our Lutein Dimer engineering service is dedicated to pursuing the following production goals:

High Specificity and Purity

Directed evolution ensures the Dimerization Enzyme produces only the desired active isomer, solving the low activity problem from chemical mixtures.

Simplified Production Process

Replacing multiple steps in chemical synthesis with a single biological step streamlines manufacturing, reduces waste, and lowers costs.

High Volumetric Productivity Icon

Optimized MEP and Lutein pathways ensure high Lutein titer as the precursor, maximizing the final Dimer yield.

Enhanced Bioactivity Icon

Production of a high-purity, specific isomer ensures the maximal therapeutic and cosmetic effect of the Lutein Dimer .

Green Synthesis Route Icon

Microbial fermentation is an environmentally friendly alternative, avoiding toxic solvents and harsh conditions of chemical synthesis.

We provide a sustainable, high-performance, and high-purity biosynthetic route for Lutein Dimer .

Process

Our Lutein Dimer strain engineering service follows a rigorous, multi-stage research workflow:

  • Lutein Pathway Construction : Introduce and optimize the Lutein gene cluster ( CrtE , B , I , Y , Z , E ) and upregulate the native MEP pathway in E. coli .
  • Dimerization Enzyme Cloning : Identify and clone a novel oxidase or synthase capable of Lutein dimer formation .
  • Directed Evolution : Subject the Dimerization Enzyme gene to error - prone PCR and high - throughput screening to isolate variants with improved activity and selectivity.
  • Metabolic Flux Optimization : Engineer central metabolism ( e.g. , Pfk or Tkt regulation) to maximize the supply of MEP pathway precursors ( Pyruvate and G3P ).
  • Functional and Titer Assays: Validate the engineered strain in fed-batch culture, measuring the final Lutein Dimer titer, yield, and isomer purity .
  • Result Report Output: Compile a detailed Experimental Report including gene modification data, enzyme directed evolution results, and fermentation metrics (volumetric titer and specific Dimer isomer ratio ) , supporting industrial scale-up.

Technical communication is maintained throughout the process, focusing on timely feedback regarding yield and product specificity.

Explore the potential for a stable, highly active Lutein Dimer supply. CD Biosynsis provides customized strain and enzyme engineering solutions:

  • Detailed Dimerization Selectivity and Activity Report , demonstrating the functional enhancement of the Directed Evolution Enzyme Variant .
  • Consultation on optimized fermentation conditions ( e.g. , light exposure, DO level) to maximize Lutein conversion.
  • Experimental reports include complete raw data on total Lutein Dimer production ( mg/L ) and final product stereochemistry , essential for cosmetic and pharmaceutical quality control.

FAQ (Frequently Asked Questions)

Still have questions?

Contact Us

Why is Directed Evolution needed for the dimerization enzyme?

Natural enzymes may have low activity or poor selectivity for a novel substrate like Lutein Dimer . Directed evolution rapidly mutates and screens the enzyme to artificially evolve it to be highly efficient and selective for the specific, desired dimerization reaction, overcoming the low activity challenge.

How does biosynthesis simplify the chemical process?

Chemical synthesis of dimers involves multiple harsh steps ( oxidation , coupling , purification ). Biosynthesis replaces all these steps with a single, highly selective enzymatic reaction inside the cell, significantly reducing the complexity, time, and cost.

What is the challenge with the Lutein pathway in E. coli ?

Lutein synthesis requires seven or more heterologous genes ( Crt cluster ) to be co-expressed, and the reaction intermediates are prone to degradation. Optimizing the expression levels and ensuring maximal flux through all steps is a major metabolic engineering challenge.

Why is E. coli chosen over Yeast for this product?

E. coli has a highly active MEP pathway for Isoprenoid precursor supply, often leading to higher carotenoid titers than the MVA pathway in yeast. It is also an easily manipulated host for large-scale fermentation.

What is the estimated project timeline?

A project involving multi-gene pathway construction, enzyme identification, and extensive directed evolution typically requires 26-30 weeks for final strain delivery and comprehensive performance validation.

0

There is no product in your cart.